tirzepatide isoelectric point (TZP) is a 39-amino acid peptide composed of both native Tirzepatide - The Darling Center

In some cases, people taking Tirzepatide have lost more than 20% of their starting body weight

Weekly weigh-ins, appetite ratings, and progress photos create a data trail that can reveal potency issues before they become obvious

In December 2025, Eli Lilly announced topline results from the phase-3 TRIUMPH-4 clinical trial evaluating the safety and efficacy of retatrutide in adults with obesity or overweight and knee osteoarthritis, and without diabetes, as an adjunct to healthy diet and physical activity

And here is the crucial detail: semaglutide is already doing much of the heavy lifting by naturally reducing her appetite by roughly 24%